ARCHIVES

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

This article is from The Cancer Letter archive.

Vol. 38 No. 40 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

In Brief: NIH Minority Program Model For Universities, Califano Says; viral Oncology Move Dropped

February 25, 1977

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991